Oncologic Outcomes of Stage IVB or Persistent or Recurrent Cervical Carcinoma Patients Treated With Chemotherapy at Siriraj Hospital: Thailand's Largest Tertiary Referral Center

about

Oncologic Outcomes of Stage IVB or Persistent or Recurrent Cervical Carcinoma Patients Treated With Chemotherapy at Siriraj Hospital: Thailand's Largest Tertiary Referral Center

Item

http://www.wikidata.org/entity/Q37036496

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Oncologic Outcomes of Stage IV ...... rgest Tertiary Referral Center

@en

Oncologic Outcomes of Stage IV ...... gest Tertiary Referral Center.

@nl

type

Item

label

Oncologic Outcomes of Stage IV ...... rgest Tertiary Referral Center

@en

Oncologic Outcomes of Stage IV ...... gest Tertiary Referral Center.

@nl

prefLabel

Oncologic Outcomes of Stage IV ...... rgest Tertiary Referral Center

@en

Oncologic Outcomes of Stage IV ...... gest Tertiary Referral Center.

@nl

P1476

Oncologic Outcomes of Stage IV ...... rgest Tertiary Referral Center

@en

P2093

Chairat Leelaphatanadit

http://www.w3.org/2001/XMLSchema#string

Irene Ruengkhachorn

http://www.w3.org/2001/XMLSchema#string

Saowalak Hunnangkul

http://www.w3.org/2001/XMLSchema#string

Suwanit Therasakvichya

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.

Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.

Improved survival with bevacizumab in advanced cervical cancer

The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy.

Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer.

Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.

Treatment of advanced or recurrent cervical cancer with Cisplatin or Cisplatin containing regimens: a cost effective analysis.

A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer.

P304

1154-1161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/IGC.0000000000000712

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27051060

http://www.w3.org/2001/XMLSchema#string

P921

An Téalainn

chemotherapy

P932

4920274

http://www.w3.org/2001/XMLSchema#string